Palermo, Italy

Ester Badami

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fondazione Ri.med, Istituto Mediterraneo Per I Trapianti E Terapie Ad Alta Specializzazione . Ismett. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ester Badami. Retrieved from https://idiyas.com/inventor/ester-badami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ester Badami: Innovator in NK-Mediated Immunotherapy

Introduction

Ester Badami is a prominent inventor based in Palermo, Italy. She has made significant contributions to the field of immunotherapy, particularly through her innovative methods for producing activated natural killer (NK) cells. Her work focuses on advancing treatments for various cancers and viral infections.

Latest Patents

Ester Badami holds a patent for her invention titled "NK-mediated immunotherapy and uses thereof." This patent describes a method for producing activated CD3-CD56+ NK cells, which can be utilized in treating tumors, specifically hepatocellular carcinoma (HCC). The invention also addresses the treatment and prevention of HCV infections and post-liver transplant complications. Additionally, it includes pharmaceutical compositions that incorporate these activated NK cells.

Career Highlights

Throughout her career, Ester has worked with notable organizations that focus on medical research and transplantation. She has been associated with the Fondazione Ri.med and the Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, also known as Ismett. Her work in these institutions has contributed to advancements in medical therapies and patient care.

Collaborations

Due to space limitations, the collaborations section has been omitted.

Conclusion

Ester Badami's innovative work in NK-mediated immunotherapy showcases her dedication to improving cancer treatment and viral infection management. Her contributions are paving the way for future advancements in the field of immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…